Holon
Israel
24
2024-03-28
22
2025-05-27
These are the the leading inventors for applications assigned to Compugen Ltd.:
Compugen Ltd. based in Holon, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-PVRIG antibodies and methods of use
#2 | 2024-03-07 ✅ Patent 12,558,421 granted on 2026-02-24ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF
#3 | 2023-03-09 ✅ Patent 12,152,084 granted on 2024-11-26Triple combination antibody therapies
#4 | 2022-06-02COMBINATIONS OF ANTI-ILDR2 ANTIBODIES AND PD-1 ANTAGONISTS
#5 | 2021-06-24 ✅ Patent 11,795,220 granted on 2023-10-24Anti-PVRIG antibodies and methods of use
#6 | 2021-01-07 ✅ Patent 11,701,424 granted on 2023-07-18Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
#7 | 2020-12-10 ✅ Patent 11,795,209 granted on 2023-10-24PVRIG polypeptides and methods of treatment
#8 | 2020-11-26 ✅ Patent 11,655,297 granted on 2023-05-23ILDR2 antagonists and combinations thereof
#9 | 2020-05-14 ✅ Patent 11,623,955 granted on 2023-04-11Anti-PVRIG antibodies and methods of use
#10 | 2019-01-10 ✅ Patent 11,225,523 granted on 2022-01-18Triple combination antibody therapies
#11 | 2018-10-25 ✅ Patent 10,751,415 granted on 2020-08-25Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
#12 | 2018-10-04 ✅ Patent 10,213,505 granted on 2019-02-26Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof
#13 | 2018-08-30 ✅ Patent 10,351,625 granted on 2019-07-16Anti-PVRIG antibodies and methods of use
#14 | 2018-06-21 ✅ Patent 10,124,061 granted on 2018-11-13Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
#15 | 2017-08-17POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS
#16 | 2017-03-30 ✅ Patent 10,550,173 granted on 2020-02-04PVRIG polypeptides and methods of treatment
#17 | 2017-03-23 ✅ Patent 9,714,289 granted on 2017-07-25Anti-PVRIG antibodies and methods of use
#18 | 2017-02-02 ✅ Patent 11,220,542 granted on 2022-01-11Anti-PVRIG antibodies and methods of use
#19 | 2016-08-25 ✅ Patent 10,227,408 granted on 2019-03-12Anti-PVRIG antibodies and methods of use
#20 | 2015-06-11 ✅ Patent 9,617,336 granted on 2017-04-11C10RF32 antibodies, and uses thereof for treatment of cancer
#21 | 2014-12-11 ✅ Patent 9,555,087 granted on 2017-01-31Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#22 | 2014-06-19 ✅ Patent 9,428,574 granted on 2016-08-30Polypeptides and uses thereof for treatment of autoimmune disorders and infection
#23 | 2014-02-13 ✅ Patent 9,409,987 granted on 2016-08-09Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
#24 | 2012-11-29 ✅ Patent 9,428,586 granted on 2016-08-30Heparanase splice variant
Also check out Compugen Ltd.'s (Holon, Israel) applicant profile with 30 patent applications submitted.
125500 ⎘